Moody’s assigns Baa1 issuer rating to Sun Pharma; outlook stable
Moody’s Ratings assigned a Baa1 long-term issuer rating to Sun Pharmaceutical Industries Limited. The rating outlook is stable.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.